Realta Investment Advisors’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-13,815
Closed -$274K 349
2020
Q1
$274K Sell
13,815
-365
-3% -$9.21K 0.12% 216
2019
Q4
$430K Sell
14,180
-699
-5% -$17.5K 0.12% 204
2019
Q3
$337K Sell
14,879
-1,165
-7% -$28.9K 0.09% 235
2019
Q2
$392K Buy
16,044
+700
+5% +$16.7K 0.11% 212
2019
Q1
$372K Buy
+15,344
New +$347K 0.17% 173

Other funds holding EDIT

Realta Investment Advisors's EDIT Position: Q2 2020 in Review

Realta Investment Advisors sold out of Editas Medicine (EDIT) in Q2 2020, closing a stake of 13,815 shares — an estimated $274K sold.

Realta Investment Advisors first reported a position in EDIT in Q1 2019 and held it in 5 quarters. The position peaked at $430K in Q4 2019. 238 funds tracked by Wall St. Rank hold EDIT as of Q2 2020.

  • Realta Investment Advisors reported no remaining Editas Medicine position as of Q2 2020 after selling out during the quarter.
  • Realta Investment Advisors sold 13,815 Editas Medicine shares in Q2 2020, an estimated $274K.
  • Realta Investment Advisors first reported a position in Editas Medicine in Q1 2019 and held it in 5 quarters.
  • Realta Investment Advisors's Editas Medicine position peaked at $430K in Q4 2019.
  • 238 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2020.

Based on Realta Investment Advisors's 13F filing for Q2 2020, filed 16 Jul 2020.